Menveo Vaccine
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Menveo Vaccine is a meningococcal groups A, C, W-135 and Y conjugate vaccine. Its labelling describes it for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135, for use in children from 2 months of age, adolescents, and adults. It is given by a healthcare professional as an injection.
Product Information
The following description reflects information associated with the meningococcal ACWY conjugate vaccine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the prevention of invasive meningococcal disease caused by serogroups A, C, W-135, and Y
- Described for use in children from 2 months of age, adolescents, and adults
- Described as prompting the immune system to produce protective antibodies without causing illness
Described Dosage & Administration
- Administered only by a doctor or nurse as an injection — not self-administered
- The dose and schedule are set by the doctor according to age
- Any course of doses should be completed as advised
Described Side Effects
Commonly described side effects include:
- Injection-site reaction
- Sleepiness
- Nausea
- Headache
- Irritability
- Muscle pain
These are described as temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be told about any past or present illness
- The doctor should be told about all current medicines
- Pregnant or breastfeeding women should consult their doctor beforehand
- Any previous allergic reaction to a vaccine or vaccine component should be disclosed beforehand
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it is a meningococcal groups A, C, W-135 and Y conjugate vaccine used to help prevent invasive meningococcal disease caused by these serogroups, for children from 2 months of age, adolescents, and adults. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling states it is administered by a doctor or nurse as an injection, at the dose and schedule set by the doctor according to age. It is not self-administered.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.